← Back
$AKBA All transactions

Akebia Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$116K

Shares

83,689

Price

$1

Filed

Feb 4

Insider

Name

Butler John P.

Title

CEO and President

CIK

0001591467

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,297,794

Footnotes

This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023. | This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. | This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. | This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025. | As reported in February 2025, the Reporting Person was granted performance-based restricted stock units ("PSUs") pursuant to the Issuer's 2023 Stock Incentive Plan, as amended. Each PSU right represents a contingent right to receive one share of the Issuer's common stock. One-half of the total number of shares of common stock underlying the PSUs vests on the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $3.50 over a 30-day trading period (the "Stock Price Hurdle 1 Performance Condition"), subject to the reporting persons continuous employment through the applicable vesting date. In July2025, the Compensation Committee certified that the Stock Price Hurdle 1 Performance Condition was met during the performance period and therefore one-half of the PSUs vested on January 31, 2026. | This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's performance stock units granted on January 31, 2025.

Filing Info

Accession No.

0001591467-26-000002

Form Type

4

Issuer CIK

0001517022

Butler John P.'s History

Date Ticker Type Value
2026-02-02 AKBA $65K
2026-02-02 AKBA $134K
2026-02-02 AKBA $160K
2026-02-02 AKBA A $247K
2026-02-02 AKBA $116K
2026-01-30 AKBA A $0
2026-01-30 AKBA A $0

Other Insiders at AKBA (90d)

Insider Bought Sold Last
Butler John P.
CEO and President
$358K 2026-02-02
Burke Steven Keith
SVP, Chief Medical Officer
$94K 2026-02-02
Vickers Philip J. 2026-04-01
Grund Nicholas
Chief Commercial Officer
$118K 2026-02-02
Ostrowski Erik
SVP, CFO, CBO & Treasurer
$49K 2026-02-02
Malabre Richard C
SVP, Chief Accounting Officer
$69K 2026-02-02
Rucci Carolyn M.
SVP, Chief Legal Officer
$97K 2026-02-02